Carna Biosciences Inc
TSE:4572

Watchlist Manager
Carna Biosciences Inc Logo
Carna Biosciences Inc
TSE:4572
Watchlist
Price: 387 JPY -6.75% Market Closed
Market Cap: 7.4B JPY

Intrinsic Value

The intrinsic value of one Carna Biosciences Inc stock under the Base Case scenario is 160.87 JPY. Compared to the current market price of 387 JPY, Carna Biosciences Inc is Overvalued by 58%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
160.87 JPY
Overvaluation 58%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Carna Biosciences Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about Carna Biosciences Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Carna Biosciences Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Carna Biosciences Inc.

Explain Valuation
Compare Carna Biosciences Inc to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Carna Biosciences Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Carna Biosciences Inc

Current Assets 1.5B
Cash & Short-Term Investments 924.8m
Receivables 71.2m
Other Current Assets 486.8m
Non-Current Assets 52.5m
Other Non-Current Assets 52.5m
Current Liabilities 161.6m
Other Current Liabilities 161.6m
Non-Current Liabilities 509.7m
Long-Term Debt 451.4m
Other Non-Current Liabilities 58.3m
Efficiency

Free Cash Flow Analysis
Carna Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Carna Biosciences Inc

Revenue
544.4m JPY
Cost of Revenue
-172.1m JPY
Gross Profit
372.3m JPY
Operating Expenses
-2.4B JPY
Operating Income
-2B JPY
Other Expenses
-140m JPY
Net Income
-2.2B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Carna Biosciences Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Declining Gross Margin
Declining Net Margin
15/100
Profitability
Score

Carna Biosciences Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Carna Biosciences Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Negative Net Debt
Long-Term Solvency
45/100
Solvency
Score

Carna Biosciences Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Carna Biosciences Inc

There are no price targets for Carna Biosciences Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Carna Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Carna Biosciences Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Carna Biosciences Inc stock?

The intrinsic value of one Carna Biosciences Inc stock under the Base Case scenario is 160.87 JPY.

Is Carna Biosciences Inc stock undervalued or overvalued?

Compared to the current market price of 387 JPY, Carna Biosciences Inc is Overvalued by 58%.

Back to Top